TITLE

Gender-related differences in the clinical presentation of malignant and benign pheochromocytoma

AUTHOR(S)
Edwin Lai; Shiromi Perera; Frederieke Brouwers; Beverly McElroy; Karen Adams; Shoichiro Ohta; Robert Wesley; Graeme Eisenhofer; Karel Pacak
PUB. DATE
December 2008
SOURCE
Endocrine (1355008X);Dec2008, Vol. 34 Issue 1-3, p96
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Abstract  Signs and symptoms associated with pheochromocytomas are predominantly caused by catecholamine excess, but tend to be highly variable and non-specific. In this study, we evaluated 23 male and 35 female pheochromocytoma patients for symptoms and signs of pheochromocytoma with special regard to gender-related differences in presentation. Total symptom score comparison between genders showed significant differences (12.0 vs. 7.8, P-value 0.0001). Female patients reported significantly more headache (80% vs. 52%), dizziness (83% vs. 39%), anxiety (85% vs. 50%), tremor (64% vs. 33%), weight change (88% vs. 43%), numbness (57% vs. 24%), and changes in energy level (89% vs. 64%). Females and males displayed comparable biochemical phenotypes (60% and 65% noradrenergic phenotype, respectively). Use of α- and/or β-blockade between males and females did not differ significantly. Subgroup analyses and multiple regression analysis revealed gender differences to be irrespective of benign or malignant disease, use of adrenoceptor-blockade, age and biochemical phenotype. We conclude female patients have significantly more self-reported pheochromocytoma signs and symptoms than male patients irrespective of biochemical phenotype and tumor presentation which may be related to distinct catecholamine receptor sensitivity. Clinicians should be aware of these complaints in female pheochromocytoma patients and offer adequate treatment if indicated.
ACCESSION #
36232733

 

Related Articles

  • β2-Adrenergic receptor gene variants and risk for autism in the AGRE cohort. Cheslack-Postava, K.; Fallin, M. D.; Avramopoulos, D.; Connors, S. L.; Zimmerman, A. W.; Eberhart, C. G.; Newschaffer, C. J. // Molecular Psychiatry;Mar2007, Vol. 12 Issue 3, p283 

    The β2-adrenergic receptor is part of the catecholamine system, and variants at two polymorphic sites in the gene coding for the receptor (ADRB2) confer increased activity. Overstimulation of this receptor may alter brain development, and has been linked to autism in non-identical twins. The...

  • Migraine After Years of Hypertension. Culp, Laura A.; Carson 3rd, Culley C. // Cortlandt Forum;12/20/99, Vol. 12 Issue 12, p168 

    Presents a medical case involving a patient diagnosed with pheochromocytoma. Clinical symptoms; Possible release of massive amounts of catecholamines; Documented stimuli for hypertensive paroxysm.

  • Plasma metanephrines in the diagnosis of pheochromocytoma. Lenders, Jacques W.M.; Keiser, Harry R. // Annals of Internal Medicine;7/15/95, Vol. 123 Issue 2, p101 

    Examines whether tests for plasma metanephrines, the omicron-methylated metabolites of catecholamines, offer advantages for diagnosis of a pheochromocytoma over standard tests for plasma catecholamines or urinary metanephrines. Catecholamine metabolism; Comparison of sensitivity, specificity,...

  • Brown Adipose Tissue in Humans Is Activated by Elevated Plasma Catecholamines Levels and Is Inversely Related to Central Obesity. Qidi Wang; Min Zhang; Guang Ning; Weiqiong Gu; Tingwei Su; Min Xu; Biao Li; Weiqing Wang // PLoS ONE;2011, Vol. 6 Issue 6, p1 

    Background: Recent studies have shown that adult human possess active brown adipose tissue (BAT), which might be important in controlling obesity. It is known that ß-adrenoceptor-UCP1 system regulates BAT in rodent, but its influence in adult humans remains to be shown. The present study is...

  • β3-Adrenergic stimulation produces a decrease of cardiac contractility ex vivo in mice overexpressing the human β3-adrenergic receptor Tavernier, Geneviève; Toumaniantz, Gilles; Erfanian, Mortéza; Heymann, Marie-France; Laurent, Karine; Langin, Dominique; Gauthier, Chantal // Cardiovascular Research;Aug2003, Vol. 59 Issue 2, p288 

    Objectives: The regulation of cardiac function by catecholamines involves three populations of β-adrenoceptor (β-AR). β1- and β2-AR stimulations produce an increase in contractility and β3-AR stimulation mediates a negative inotropic effect in human ventricular muscle....

  • The effect of catecholamines on the glucose uptake in brown adipose tissue demonstrated by 18F-FDG PET/CT in a patient with adrenal pheochromocytoma. Lilian Yuri Yamaga; Thom, Anneliese Fischer; Wagner, Jairo; Baroni, Ronaldo Hueb; Hidal, Jairo Tabacow; Funari, Marcelo Gusmão // European Journal of Nuclear Medicine & Molecular Imaging;Feb2008, Vol. 35 Issue 2, p446 

    The article focuses on the diagnosis of a 50-year-old man with adrenal pheochromocytoma. The diagnosis discovers that the patient had a tumor in his right adrenal. It discovers that the patient has a brown adipose tissue (BAT) in his neck, supraclavicular, mediastinal and perinephric regions....

  • Brainstem tumour mimicking pheochromocytoma. Melo, N. C. V.; Carmo, L. P. F.; Rodrigues, C. E.; Marques, I. D. B.; Praxedes, J. N. // Journal of Human Hypertension;Jul2009, Vol. 23 Issue 7, p493 

    The diagnosis of a catecholamine-secreting pheochromocytoma is always suggested by occurrence of severe and symptomatic paroxysmal hypertension. However, in most patients this diagnosis is not confirmed, despite extensive investigation. Traditionally, besides pheochromocytoma, the differential...

  • Evaluation of the clonidine suppression test in the diagnosis of phaeochromocytoma. McHenry, C. M.; Hunter, S. J.; McCormick, M. T.; Russell, C. F.; Smye, M. G.; Atkinson, A. B. // Journal of Human Hypertension;Jul2011, Vol. 25 Issue 7, p451 

    The aim of this study is to review the experience of the clonidine suppression test in a regional endocrine centre and to compare the diagnostic sensitivity and specificity using various previous published criteria. The design used is retrospective study. The subjects include 56 patients in whom...

  • Subjective sleepiness and daytime functioning in bariatric patients with obstructive sleep apnea. Sharkey, Katherine; Orff, Henry; Tosi, Christine; Harrington, David; Roye, G.; Millman, Richard // Sleep & Breathing;Mar2013, Vol. 17 Issue 1, p267 

    Purpose: The purpose of this study was to evaluate associations between obstructive sleep apnea (OSA) severity and self-reported sleepiness and daytime functioning in patients considering bariatric surgery for treatment of obesity. Methods: Using a retrospective cohort design, we identified 342...

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics